Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter D R Higgins

Showing results (31-40 of 246) with videos related to

Pageof 25
Sort By:
The American Journal of Gastroenterology|July 4, 2014
Response to Feagan et alShail M Govani, Akbar K Waljee, Peter D R Higgins
The American Journal of Gastroenterology|December 5, 2013
Anti-adhesion therapies and the rule of 3 for rare eventsShail M Govani, Akbar K Waljee, Peter D R Higgins
Clinical and Translational Gastroenterology|January 4, 2014
A primer on effectiveness and efficacy trialsAmit G Singal, Peter D R Higgins, Akbar K Waljee
Inflammatory Bowel Diseases|September 30, 2021
Efficacy of Ustekinumab in Crohn's Disease With and Without Concurrent Autoimmune Skin DiseaseElena Fradkov, Jessica Sheehan, Kelly Cushing, et al.
Inflammatory Bowel Diseases|December 6, 2008
Voting With their Feet (VWF) endpoint: a meta-analysis of an alternative endpoint in clinical trials, using 5-ASA induction studies in ulcerative colitisSujal C Rangwalla, Akbar K Waljee, Peter D R Higgins
Journal of Crohn'S & Colitis|July 25, 2013
How early to take arms against a sea of troubles? The case for aggressive early therapy in Crohn's disease to prevent fibrotic intestinal stricturesShail M Govani, Ryan W Stidham, Peter D R Higgins
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 28, 2020
ReplyJeffrey A Berinstein, Calen A Steiner, Peter D R Higgins
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 22, 2012
Cost utility of inflammation-targeted therapy for patients with ulcerative colitisSameer D Saini, Akbar K Waljee, Peter D R Higgins
Inflammatory Bowel Diseases|May 21, 2016
Endoscopic Mucosal Healing Predicts Favorable Clinical Outcomes in Inflammatory Bowel Disease: A Meta-analysisAndrew R Reinink, Terrence C Lee, Peter D R Higgins
Clinical and Translational Gastroenterology|January 4, 2014
A primer on predictive modelsAkbar K Waljee, Peter D R Higgins, Amit G Singal
Pageof 25

Showing results (31-40 of 246) with videos related to

Sort By:
Pageof 25
The American Journal of Gastroenterology|July 4, 2014
Response to Feagan et alShail M Govani, Akbar K Waljee, Peter D R Higgins
The American Journal of Gastroenterology|December 5, 2013
Anti-adhesion therapies and the rule of 3 for rare eventsShail M Govani, Akbar K Waljee, Peter D R Higgins
Clinical and Translational Gastroenterology|January 4, 2014
A primer on effectiveness and efficacy trialsAmit G Singal, Peter D R Higgins, Akbar K Waljee
Inflammatory Bowel Diseases|September 30, 2021
Efficacy of Ustekinumab in Crohn's Disease With and Without Concurrent Autoimmune Skin DiseaseElena Fradkov, Jessica Sheehan, Kelly Cushing, et al.
Inflammatory Bowel Diseases|December 6, 2008
Voting With their Feet (VWF) endpoint: a meta-analysis of an alternative endpoint in clinical trials, using 5-ASA induction studies in ulcerative colitisSujal C Rangwalla, Akbar K Waljee, Peter D R Higgins
Journal of Crohn'S & Colitis|July 25, 2013
How early to take arms against a sea of troubles? The case for aggressive early therapy in Crohn's disease to prevent fibrotic intestinal stricturesShail M Govani, Ryan W Stidham, Peter D R Higgins
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 28, 2020
ReplyJeffrey A Berinstein, Calen A Steiner, Peter D R Higgins
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 22, 2012
Cost utility of inflammation-targeted therapy for patients with ulcerative colitisSameer D Saini, Akbar K Waljee, Peter D R Higgins
Inflammatory Bowel Diseases|May 21, 2016
Endoscopic Mucosal Healing Predicts Favorable Clinical Outcomes in Inflammatory Bowel Disease: A Meta-analysisAndrew R Reinink, Terrence C Lee, Peter D R Higgins
Clinical and Translational Gastroenterology|January 4, 2014
A primer on predictive modelsAkbar K Waljee, Peter D R Higgins, Amit G Singal
Pageof 25